Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.

Author: BaghaiT, BergerM, CohrsS, FischerW, HajakG, HoffmannM, HohagenF, LaakmannG, MayerG, RiemannD, RodenbeckA, RütherE, VoderholzerU, WiegandM H

Paper Details 
Original Abstract of the Article :
In recent years, sedating antidepressants have been increasingly used to treat primary insomnia. Up to now, only one open pilot study with trimipramine and one double-blind placebo-controlled study with doxepin have provided scientific support for this approach in treating primary insomnia. In order...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1055/s-2002-34119

データ提供:米国国立医学図書館(NLM)

Evaluating the Effectiveness of Trimipramine for Primary Insomnia

This study investigates the efficacy of trimipramine, a sedating antidepressant, in treating primary insomnia. It's like exploring the vast desert of sleep disorders, seeking a reliable oasis of restful slumber. The researchers conducted a double-blind placebo- and lormetazepam-controlled study, comparing the effects of trimipramine to placebo and a benzodiazepine, lormetazepam, on objectively and subjectively measured sleep parameters in individuals with primary insomnia.

Trimipramine's Positive Effects on Sleep Efficiency

The study found that trimipramine, at an average dose of 100 mg over a 4-week period, significantly improved sleep efficiency, but not total sleep time. This is like finding a small, hidden oasis in the vast desert of sleep problems, providing some relief but not a complete solution. The improvements in objective sleep parameters were paralleled by changes in subjective sleep parameters, suggesting that the drug's effects were perceived by the individuals experiencing insomnia. Importantly, trimipramine did not suppress REM sleep, unlike lormetazepam, which decreased wake time and sleep stage 3 and increased REM sleep compared to placebo.

Potential Benefits and Considerations for Treatment

This research suggests that trimipramine may be a viable treatment option for primary insomnia. However, the study notes that the large individual variations in sleep parameters require further research to fully confirm its efficacy. It's important to remember that the desert of insomnia is vast and diverse, and individuals respond to treatment differently. As with any medication, trimipramine should be used under the guidance of a healthcare professional who can carefully monitor potential side effects and tailor treatment plans to individual needs.

Dr.Camel's Conclusion

This study provides valuable insights into the potential of trimipramine as a treatment for primary insomnia. While further research is needed, the findings suggest that it may offer a viable option for individuals struggling with sleep problems. As with any journey through the desert of health, it's crucial to seek guidance from qualified professionals and to approach treatments with an understanding of individual variations and potential risks.

Date :
  1. Date Completed 2003-01-17
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

12237787

DOI: Digital Object Identifier

10.1055/s-2002-34119

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.